Roivant (ROIV) Director Daniel Gold Receives RSU & Option Awards

What Happened

Daniel Allen Gold, a Roivant Sciences Ltd. (ROIV) director, received equity awards on September 16, 2026: 5,054 restricted stock units (RSUs) and 10,531 stock options. Both awards show an acquisition price of $0.00 on the Form 4 because these were grants under the company’s 2021 Equity Incentive Plan and the Non‑Employee Director Compensation Policy, not open‑market purchases.

Key Details

• Transaction date: 2026-09-16 (reported on Form 4 filed 2026-09-18 — timely within the 2‑business‑day window).
• Type: A = Award/Grant (RSUs and stock options); price reported $0.00.
• RSUs granted: 5,054; Stock options granted: 10,531 (options are derivative awards).
• Vesting: Both awards scheduled to vest 100% on September 16, 2027, subject to continued service as a director (see footnotes F1 and F2).
• Shares owned after transaction: Not specified in the provided filing.
• No exercise, sale, or cashless transaction reported — these are grants, not immediate sales or exercises.

Context

RSUs and stock options are common components of director compensation. RSUs convert to shares only after vesting; options must be exercised (and may have a strike price and exercise rules not detailed in this filing) before creating owned shares. Because these are awards tied to continued service, they do not represent an immediate purchase or sale and should be viewed as part of routine compensation disclosures rather than a direct market signal.